BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

659 related articles for article (PubMed ID: 19324130)

  • 1. Renal function and outcome after continuous flow left ventricular assist device implantation.
    Sandner SE; Zimpfer D; Zrunek P; Rajek A; Schima H; Dunkler D; Grimm M; Wolner E; Wieselthaler GM
    Ann Thorac Surg; 2009 Apr; 87(4):1072-8. PubMed ID: 19324130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal function after implantation of continuous versus pulsatile flow left ventricular assist devices.
    Sandner SE; Zimpfer D; Zrunek P; Dunkler D; Schima H; Rajek A; Grimm M; Wolner E; Wieselthaler GM
    J Heart Lung Transplant; 2008 May; 27(5):469-73. PubMed ID: 18442710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age and outcome after continuous-flow left ventricular assist device implantation as bridge to transplantation.
    Sandner SE; Zimpfer D; Zrunek P; Rajek A; Schima H; Dunkler D; Zuckermann AO; Wieselthaler GM
    J Heart Lung Transplant; 2009 Apr; 28(4):367-72. PubMed ID: 19332264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in renal function after implantation of continuous-flow left ventricular assist devices.
    Hasin T; Topilsky Y; Schirger JA; Li Z; Zhao Y; Boilson BA; Clavell AL; Rodeheffer RJ; Frantz RP; Edwards BS; Pereira NL; Joyce L; Daly R; Park SJ; Kushwaha SS
    J Am Coll Cardiol; 2012 Jan; 59(1):26-36. PubMed ID: 22192665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors and outcomes of continuous veno-venous hemodialysis use after implantation of a left ventricular assist device.
    Topkara VK; Dang NC; Barili F; Cheema FH; Martens TP; George I; Bardakci H; Oz MC; Naka Y
    J Heart Lung Transplant; 2006 Apr; 25(4):404-8. PubMed ID: 16563969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between renal function and left ventricular assist device use.
    Butler J; Geisberg C; Howser R; Portner PM; Rogers JG; Deng MC; Pierson RN
    Ann Thorac Surg; 2006 May; 81(5):1745-51. PubMed ID: 16631666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. End-organ function in patients on long-term circulatory support with continuous- or pulsatile-flow assist devices.
    Radovancevic B; Vrtovec B; de Kort E; Radovancevic R; Gregoric ID; Frazier OH
    J Heart Lung Transplant; 2007 Aug; 26(8):815-8. PubMed ID: 17692785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
    Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Naka Y; Mancini D; Miller LW
    Circulation; 2007 Jul; 116(5):497-505. PubMed ID: 17638928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure.
    Dang NC; Topkara VK; Mercando M; Kay J; Kruger KH; Aboodi MS; Oz MC; Naka Y
    J Heart Lung Transplant; 2006 Jan; 25(1):1-6. PubMed ID: 16399523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal and hepatic function improve in advanced heart failure patients during continuous-flow support with the HeartMate II left ventricular assist device.
    Russell SD; Rogers JG; Milano CA; Dyke DB; Pagani FD; Aranda JM; Klodell CT; Boyle AJ; John R; Chen L; Massey HT; Farrar DJ; Conte JV;
    Circulation; 2009 Dec; 120(23):2352-7. PubMed ID: 19933938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular assist device destination therapy versus extended criteria cardiac transplant.
    Daneshmand MA; Rajagopal K; Lima B; Khorram N; Blue LJ; Lodge AJ; Hernandez AF; Rogers JG; Milano CA
    Ann Thorac Surg; 2010 Apr; 89(4):1205-9; discussion 1210. PubMed ID: 20338335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Right heart failure and "failure to thrive" after left ventricular assist device: clinical predictors and outcomes.
    Baumwol J; Macdonald PS; Keogh AM; Kotlyar E; Spratt P; Jansz P; Hayward CS
    J Heart Lung Transplant; 2011 Aug; 30(8):888-95. PubMed ID: 21530314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era.
    Topkara VK; Kondareddy S; Malik F; Wang IW; Mann DL; Ewald GA; Moazami N
    Ann Thorac Surg; 2010 Oct; 90(4):1270-7. PubMed ID: 20868826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients.
    Kamdar F; Boyle A; Liao K; Colvin-adams M; Joyce L; John R
    J Heart Lung Transplant; 2009 Apr; 28(4):352-9. PubMed ID: 19332262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does pretransplant left ventricular assist device therapy improve results after heart transplantation in patients with elevated pulmonary vascular resistance?
    Liden H; Haraldsson A; Ricksten SE; Kjellman U; Wiklund L
    Eur J Cardiothorac Surg; 2009 Jun; 35(6):1029-34; discussion 1034-5. PubMed ID: 19211259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body mass index and outcomes after left ventricular assist device placement.
    Butler J; Howser R; Portner PM; Pierson RN
    Ann Thorac Surg; 2005 Jan; 79(1):66-73. PubMed ID: 15620917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does renal dysfunction and method of bridging support influence heart transplant graft survival?
    Haglund NA; Feurer ID; Dwyer JP; Stulak JM; DiSalvo TG; Keebler ME; Schlendorf KH; Wigger MA; Maltais S
    Ann Thorac Surg; 2014 Sep; 98(3):835-41. PubMed ID: 25069689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does continuous flow left ventricular assist device technology have a positive impact on outcome pretransplant and posttransplant?
    Klotz S; Stypmann J; Welp H; Schmid C; Drees G; Rukosujew A; Scheld HH
    Ann Thorac Surg; 2006 Nov; 82(5):1774-8. PubMed ID: 17062246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.